Triptorelin (Trelstar, Decapeptyl) studies: 345 papers with results
Page 4 of 7
- Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea.
Abbara A · The Journal of clinical endocrinology and metabolism · 2023
Non-randomized trial · 4 results
- Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study.
Gil T · Therapeutic advances in urology · 2017
Observational study · 3 results
- Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer.
Breul J · Advances in therapy · 2017
Observational study · 7 results
- Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study.
Drakopoulos P · Frontiers in endocrinology · 2019
Observational study · 4 results
- A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer.
Gil T · Therapeutic advances in urology · 2015
Observational study · 2 results
- Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH · Fertility and sterility · 2013
Observational study · 4 results
- Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study.
Peltier A · Prostate cancer · 2015
Observational study · 2 results
- Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin-releasing hormone agonist for women undergoing fertility preservation.
Hong YH · Reproductive medicine and biology · 2022
Observational study · 6 results
- The effect of triptorelin and leuprolide on the level of sex hormones in girls with central precocious puberty and its clinical efficacy analysis.
Wang L · Translational pediatrics · 2021
Observational study · 9 results
- Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide.
Shim M · Investigative and clinical urology · 2019
Observational study · 6 results
- Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients.
Huser M · Human reproduction (Oxford, England) · 2008
Observational study · 3 results
- Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls.
Shiasi Arani K · International journal of endocrinology and metabolism · 2015
Observational study · 1 result
- Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study.
Valenzise M · Frontiers in pediatrics · 2023
Observational study · 5 results
- Effectiveness of the triptorelin stimulation test compared with the classic gonadotropin-releasing hormone stimulation test in diagnosing central precocious puberty in girls.
Kim YJ · Annals of pediatric endocrinology & metabolism · 2024
Observational study · 6 results
- Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study.
van den Driessche H · Drugs - real world outcomes · 2016
Observational study · 5 results
- Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome.
Homburg R · Fertility and sterility · 1993
Observational study · 4 results
- Metabolic Outcomes, Bone Health, and Risk of Polycystic Ovary Syndrome in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogues.
Faienza MF · Hormone research in paediatrics · 2017
Observational study · 8 results
- Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient-Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study.
Cornford P · Oncology and therapy · 2018
Observational study · 8 results
- Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women.
Campo S · Acta obstetricia et gynecologica Scandinavica · 2005
Observational study · 6 results
- Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty.
Arrigo T · European journal of endocrinology · 1999
Observational study · 6 results
- End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty.
Antoniazzi F · Journal of pediatric endocrinology & metabolism : JPEM · 2000
Observational study · 8 results
- Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes.
De Falco M · European journal of obstetrics, gynecology, and reproductive biology · 2009
Observational study · 6 results
- Triptorelin stimulated luteinizing hormone concentrations for diagnosing central precocious puberty: study of diagnostic accuracy.
Vukovic R · Endocrine · 2022
Observational study · 3 results
- Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study.
Del Gadillo JC · European journal of obstetrics, gynecology, and reproductive biology · 2002
Observational study · 8 results
- Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents.
Schagen SE · The journal of sexual medicine · 2016
Observational study · 11 results
- Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
Massart F · Neuroendocrinology · 2009
Observational study · 7 results
- Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
Chiocca E · Neuroendocrinology · 2009
Observational study · 7 results
- Influence of GnRH analog therapy on body mass in central precocious puberty.
Głab E · Pediatric endocrinology, diabetes, and metabolism · 2009
Observational study · 5 results
- The Influence of GnRH Analog Therapy on Growth in Central Precocious Puberty.
Głąb E · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · 2016
Observational study · 3 results
- Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
Fisher AD · The Journal of clinical endocrinology and metabolism · 2024
Observational study · 6 results
- [Change of the LHRH analogue in progressive castration-refractory prostate cancer].
Heidenreich A · Der Urologe. Ausg. A · 2012
Observational study · 6 results
- Time to menarche and final height after histrelin implant treatment for central precocious puberty.
Gillis D · The Journal of pediatrics · 2013
Observational study · 8 results
- Central precocious puberty in girls: internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues.
Jensen AM · The Journal of pediatrics · 1998
Observational study · 7 results
- Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty.
Wojniusz S · Frontiers in psychology · 2016
Observational study · 4 results
- Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments.
Antoniazzi F · Acta paediatrica (Oslo, Norway : 1992) · 1994
Observational study · 4 results
- Long-term efficacy of a triptorelin 3-month depot in girls with central precocious puberty.
Park KH · Annals of pediatric endocrinology & metabolism · 2024
Observational study · 2 results
- Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results.
Mul D · Hormone research · 2002
Observational study · 4 results
- Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment.
Sørensen K · The Journal of clinical endocrinology and metabolism · 2007
Observational study · 1 result
- Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy.
Feldberg D · Fertility and sterility · 1989
Observational study · 1 result
- Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy.
Xhrouet-Heinrichs D · Acta paediatrica (Oslo, Norway : 1992) · 1997
Observational study · 4 results
- Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.
Liang Y · Journal of pediatric endocrinology & metabolism : JPEM · 2015
Observational study · 12 results
- Central Precocious Puberty: Adult Height in Girls Treated with Quarterly or Monthly Gonadotropin-Releasing Hormone Analog Triptorelin.
Bertelloni S · Hormone research in paediatrics · 2015
Observational study · 2 results
- Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
Young J · The Journal of clinical endocrinology and metabolism · 1999
Observational study · 4 results
- Gonadotropin-releasing hormone agonist triggering is effective, even at a low dose, for final oocyte maturation in ART cycles: Case series.
Gülekli B · Journal of the Turkish German Gynecological Association · 2015
Observational study · 13 results
- Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty.
Lee JW · Annals of pediatric endocrinology & metabolism · 2014
Observational study · 1 result
- Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC · Bone · 2017
Observational study · 9 results
- Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D · Fertility and sterility · 2009
Observational study · 6 results
- Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries.
Cicione A · Prostate cancer and prostatic diseases · 2023
Observational study · 4 results
- Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline.
Elefant E · Fertility and sterility · 1995
Case report or series · 1 result
- Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.
Itskovitz-Eldor J · Human reproduction (Oxford, England) · 2000
Case report or series · 7 results